WASHINGTON — Vantor, an Earth intelligence firm formerly known as Maxar Intelligence, said Dec. 16 it is partnering with Niantic Spatial to develop navigation technology for military platforms ...
Investing.com - Goldman Sachs initiated coverage of MBX Biosciences Inc (NASDAQ:MBX) with a Sell rating and a $18.00 price target, implying 47% downside potential from the current price of $33.94.
07:49 EST MBX Biosciences (MBX) drops 4% in premarket trading after Goldman initiates with Sell Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with ...
Whether you call Dex a wheeled humanoid or a mobile manipulator, Richtech Robotics' system is a sign of things to come, says ...
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its ...
Hosted on MSN
How Much Upside is Left in MBX Biosciences, Inc. (MBX)? Wall Street Analysts Think 80.6%
Shares of MBX Biosciences, Inc. (MBX) have gained 57.1% over the past four weeks to close the last trading session at $34.49, but there could still be a solid upside left in the stock if short-term ...
Android XR is Google's operating system for VR headsets and smart glasses with Gemini AI, developer tools, and support for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback